AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2015
May 22, 2015
35424_dirs_2015-05-22_72272887-a1e5-4912-9e16-8866a0f465b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-05-20
Reporting Person: Ankrum Matthew A. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-20 | Stock Option (right to buy) | $8.00 | A | 15000 | Acquired | 2025-05-14 | Common Stock (15000) | Direct |
Footnotes
F1: The option vests in three equal annual installments on May 14, 2016, 2017, and 2018.
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Board/Management Information
2026
Feb 6
Capital/Financing Update
2026
Jan 28
Capital/Financing Update
2026
Jan 14
M&A Activity
2025
Dec 29
Regulatory Filings
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Annual Report
2025
Nov 19